These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 33549094)

  • 1. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM; Tarimo D; Chacky F; Mohamed A; Kishimba R; Samwel A
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):440. PubMed ID: 31775686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique.
    Arnaldo P; Rovira-Vallbona E; Langa JS; Salvador C; Guetens P; Chiheb D; Xavier B; Kestens L; Enosse SM; Rosanas-Urgell A
    Malar J; 2018 Mar; 17(1):109. PubMed ID: 29530044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania.
    Exavery A; Mbaruku G; Mbuyita S; Makemba A; Kinyonge IP; Kweka H
    Malar J; 2014 Jan; 13():22. PubMed ID: 24423279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
    Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
    Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of timely uptake of ITN and SP (IPT) and pregnancy time protected against malaria in Bukoba, Tanzania.
    Protas J; Tarimo D; Moshiro C
    BMC Res Notes; 2016 Jun; 9():318. PubMed ID: 27328717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon.
    Anchang-Kimbi JK; Kalaji LN; Mbacham HF; Wepnje GB; Apinjoh TO; Ngole Sumbele IU; Dionne-Odom J; Tita ATN; Achidi EA
    Malar J; 2020 Mar; 19(1):100. PubMed ID: 32122339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
    Martin MK; Venantius KB; Patricia N; Bernard K; Keith B; Allen K; Godfrey A; Rogers T; Damazo KT; Dathan BM
    Malar J; 2020 Apr; 19(1):153. PubMed ID: 32295601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kombila M
    BMC Pregnancy Childbirth; 2013 Feb; 13():52. PubMed ID: 23442536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries.
    Xu X; Liang D; Zhao J; Mpembeni R; Olenja J; Yam EL; Huang J
    J Glob Health; 2024 Jun; 14():04112. PubMed ID: 38939971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine-pyrimethamine five dose policy in Ghana.
    Owusu-Boateng I; Anto F
    Malar J; 2017 Aug; 16(1):323. PubMed ID: 28797296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana.
    Amoako BK; Anto F
    BMC Pregnancy Childbirth; 2021 Feb; 21(1):105. PubMed ID: 33530957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial distribution and determinants of intermittent preventive treatment for malaria during pregnancy: a secondary data analysis of the 2019 Ghana malaria indicators survey.
    Ndayishimiye JC; Teg-Nefaah Tabong P
    BMC Pregnancy Childbirth; 2024 May; 24(1):379. PubMed ID: 38769513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The demand for intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine in the Volta Region of Ghana.
    Asem L; Abdulia AG; Assuming PO; Abeka-Nkrumah G
    PLoS One; 2024; 19(9):e0308321. PubMed ID: 39236029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.